MDA Canada Last registration date Today Feb 1, 2013 for $300,000 Myotonic Dystrophy Grants

The Rachel Fund for Myotonic Dystrophy

Muscular Dystrophy Canada and the Institute of Musculoskeletal Health and Arthritis are pleased to announce the third joint competition of the Rachel Fund. Launched originally in 2006, the Rachel Fund is proudly supported by Tribute Communities, a generous donor to Muscular Dystrophy Canada.

Founded over 25 years ago, Tribute Communities is a leading builder of new homes and condominiums with a mission to create distinctive, visionary communities. Our exquisite lowrise communities are enhanced by natural beauty, old-world charm and a friendly ambience. Streetscapes present a fresh, bright appeal, with heritage touches that celebrate the past. Our condominiums are vibrant expressions of urban style, with iconic architecture, sophisticated designs and spectacular amenities. Whether living in a signature Tribute single family home or an elegant Tribute condominium, our customers can be sure of one thing: their home has been built by passionate people who truly care about bringing dreams to life. This is an absolute wonderful company that is very supportive of its community!

The objective of the Rachel Fund is to support research in one or both of the following themes:

  1. Research on therapeutics (pharmacological, cell based, genetic) and/or translational aspects that pertain directly to myotonic dystrophy;
  2. Research on the genetic, cellular or biochemical processes involved in myotonic dystrophy.

The total amount available for this funding opportunity is $300,000. The maximum amount awarded for a single grant is $100,000 per annum for up to 3 years. The competition will be administered as part of CIHR’s Winter 2013 Operating Grant, Priority Announcements. All applications must be submitted electronically using ResearchNet. How to apply?

Please note the following important dates:

 

 

Registration February 1, 2013
Application deadline March 1, 2013
Anticipated Notice of Decision June 28, 2013
Funding start date October 1, 2013

 

The CIHR-IMHA encourages researchers across disciplines within the arthritis, bone, skin, muscle, oral health and/or rehabilitation research communities, and across all four of CIHR research pillars, to develop research in areas covered by IMHA’s mandate and its flagship priority, physical activity, mobility and health, as these relate to myotonic dystrophy.

To apply or for more information:

Visit CIHR’s Funding Opportunities database, Operating Grants: Winter 2013 Priority Announcements Specific Research Areas

Select “Myotonic dystrophy (Rachel Fund)” under Section A: Priority Announcements and Relevant Research Area.

Note: To be considered for funding, you must remember to select the priority announcement title (i.e. Myotonic Dystrophy, Rachel Fund) in the “Identify Priority Announcements and Relevant Research Area” section of your ResearchNet application.

Questions? Please contact:

Marla Spiegel
National Director, Research
Muscular Dystrophy Canada
Telephone: 1-866-687-2538 ext 134
Email: Marla Spiegel

 

Tanya Gallant
Program Manager/Analyst
CIHR Institute of Musculoskeletal Health and Arthritis (IMHA)
Telephone: 613-954-3469
Email: Tanya Gallant

Print Friendly, PDF & Email

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.